Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.
Onconova Therapeutics, Pangea Biomed Collaborate on AI-Driven Cancer Biomarker Study
The companies will apply Pangea's ENLIGHT platform to map gene interactions in pathways modulated by Onconova's investigational cancer therapy rigosertib.
Baylor Team Aims to Identify Chemo Toxicity Biomarkers in Latino Pediatric Leukemia Patients
Premium
The CPRIT-funded study will examine clinical and genomic data from more than 2,000 Latino patients with acute lymphoblastic leukemia treated with high-dose chemo.
Metabolomics Research Services Firm Panome Bio Raises $6M
Panome Bio is advancing a biomarker- and drug-discovery platform developed by its cofounder at Washington University.
Cota, Genomic Testing Cooperative Ink Precision Oncology Partnership
The firms will combine real-world patient outcomes and clinical information with DNA and RNA sequencing data to help researchers advance personalized treatment approaches.